Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 30,058
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12576158 | Antibody drug conjugates with cleavable linkers | 🖼🧊📄§ | 2026-03-17 | 2040-05-22 | 0 | 31 |
| 12576040 | Ionizable lipids and methods of manufacture and use thereof | 🖼🧊📄§ | 2026-03-17 | 2041-10-13 | 0 | 31 |
| 12576140 | Cyclophilin 40 for reduction of neurotoxic fibrils and treatment of neurodegenerative diseases | 🖼🧊📄§ | 2026-03-17 | 2041-07-29 | 0 | 31 |
| 12576133 | Antigen-binding agents that specifically bind epidermal growth factor receptor variant III | 🖼🧊📄§ | 2026-03-17 | 2040-03-23 | 0 | 31 |
| 12576083 | Combinational therapy of LSD1 inhibitors with P21 activators in the treatment of cancer | 🖼🧊📄§ | 2026-03-17 | 2044-01-17 | 0 | 31 |
| 12576094 | Combination cannabinoid-phenylethanoid formulation for treatment of inflammation and methods related thereto | 🖼🧊📄§ | 2026-03-17 | 2040-11-20 | 0 | 31 |
| 12576077 | Composition for preventing, alleviating or treating cancer | 🖼🧊📄§ | 2026-03-17 | 2043-08-28 | 0 | 31 |
| 12576068 | Compositions containing amino acids and methods of using such compositions for treating sarcopenia | 🖼🧊📄§ | 2026-03-17 | 2041-04-01 | 0 | 31 |
| 12576104 | Dental preparation comprising fibers based on hyaluronic acid with regulated biodegradability | 🖼🧊📄§ | 2026-03-17 | 2041-01-05 | 0 | 31 |
| 12575572 | Systems, methods, and apparatuses for disinfection and decontamination | 🖼🧊📄§ | 2026-03-17 | 2043-03-24 | 0 | 31 |
| 12577292 | Ferritin nanocage for multi-displaying trail trimer and cancer-targeting peptide and use thereof as anticancer agent | 🖼🧊📄§ | 2026-03-17 | 2040-03-06 | 0 | 31 |
| 12577219 | Macrolide brefeldin a ester derivatives and use thereof | 🖼🧊📄§ | 2026-03-17 | 2041-11-10 | 0 | 31 |
| 12577252 | Drug for the treatment of diseases caused by bacteria | 🖼🧊📄§ | 2026-03-17 | 2041-04-14 | 0 | 31 |
| 12577254 | Thienopyranones and furanopyranones as kinase, bromodomain, and checkpoint inhibitors | 🖼🧊📄§ | 2026-03-17 | 2043-08-18 | 0 | 31 |
| 12577213 | Deuterated 1,4-benzodiazepine-2,5-dione compound and use thereof | 🖼🧊📄§ | 2026-03-17 | 2041-10-25 | 0 | 31 |
| 12576121 | Acacia nilotica based hydrogel and method of making the same | 🖼🧊📄§ | 2026-03-17 | 2045-12-12 | 0 | 31 |
| 12577316 | Methods of use of anti-CD37 antibodies, monoclonal anti-CD37 antibodies | 🖼🧊📄§ | 2026-03-17 | 2043-10-27 | 0 | 31 |
| 12577287 | T cell receptors and methods of use thereof | 🖼🧊📄§ | 2026-03-17 | 2040-03-24 | 0 | 31 |
| 12577324 | Antibodies having specificity to HER4 and uses thereof | 🖼🧊📄§ | 2026-03-17 | 2040-12-08 | 0 | 31 |
| 12577242 | Pyrrolopyridine and imidazopyridine antiviral compounds | 🖼🧊📄§ | 2026-03-17 | 2041-02-24 | 0 | 31 |
| 12577238 | Compositions and methods for modulating inflammatory and degenerative disorder | 🖼🧊📄§ | 2026-03-17 | 2042-08-17 | 0 | 31 |
| 12577305 | Multispecific antigen binding proteins capable of binding CD19 and CD3, and use thereof | 🖼🧊📄§ | 2026-03-17 | 2039-12-23 | 0 | 31 |
| 12577250 | 1,2,4-triazolone derivative as DHODH inhibitor, and preparation method therefor and use thereof | 🖼🧊📄§ | 2026-03-17 | 2042-07-05 | 0 | 31 |
| 12577301 | GRP78-binding antibodies and use thereof in detecting or neutralizing GRP78 | 🖼🧊📄§ | 2026-03-17 | 2044-07-12 | 0 | 31 |
| 12577267 | Pyrimidine compounds for use as MAP4K1 inhibitors | 🖼🧊📄§ | 2026-03-17 | 2042-07-06 | 0 | 31 |
| 12576074 | Kits and methods for induction of cardioversion in subjects with atrial arrhythmias | 🖼🧊📄§ | 2026-03-17 | 2043-03-20 | 0 | 31 |
| 12577201 | Glutamine analogs | 🖼🧊📄§ | 2026-03-17 | 2041-10-14 | 0 | 31 |
| 12577307 | Method and medicament for treating cancer unresponsive to PD-1/PD-L1 signaling inhibitor | 🖼🧊📄§ | 2026-03-17 | 2039-10-17 | 0 | 31 |
| 12577314 | Anti-BCMA/anti-4-1BB bispecific antibodies and uses thereof | 🖼🧊📄§ | 2026-03-17 | 2040-12-10 | 0 | 31 |
| 12576171 | Composition of radioactive and non-radioactive microparticles | 🖼🧊📄§ | 2026-03-17 | 2044-05-06 | 0 | 31 |
| 12577240 | Antiviral heteroaryl ketone derivatives | 🖼🧊📄§ | 2026-03-17 | 2041-07-07 | 0 | 31 |
| 12577280 | Glycosylated comp pilin variants, methods of making and uses thereof | 🖼🧊📄§ | 2026-03-17 | 2044-03-14 | 0 | 31 |
| 12576128 | Genetically engineered microorganisms and methods of use | 🖼🧊📄§ | 2026-03-17 | 2040-05-01 | 0 | 31 |
| 12577231 | Androgen receptor PROTACS | 🖼🧊📄§ | 2026-03-17 | 2045-06-30 | 0 | 31 |
| 12576042 | Methods and compositions for treating neurological conditions | 🖼🧊📄§ | 2026-03-17 | 2042-12-02 | 0 | 31 |
| 12576098 | Saponin containing extracts prepared from Hesperaloe useful in the treatment of non-human animals | 🖼🧊📄§ | 2026-03-17 | 2041-06-21 | 0 | 31 |
| 12576159 | Anti-human PD-1 antibody crystals and methods of use thereof | 🖼🧊📄§ | 2026-03-17 | 2039-10-28 | 0 | 31 |
| 12576024 | Compositions comprising Propionibacterium acnes bacteriophages for treating acne | 🖼🧊📄§ | 2026-03-17 | 2044-01-16 | 0 | 31 |
| 12576141 | Albumin bound macromolecule tri-agonist activating GLP-1/GIP/glucagon receptors | 🖼🧊📄§ | 2026-03-17 | 2044-06-25 | 0 | 31 |
| 12576079 | Methods for treating cholestasis | 🖼🧊📄§ | 2026-03-17 | 2040-12-11 | 0 | 31 |
| 12576067 | Methods and compositions for treatment of mydriasis | 🖼🧊📄§ | 2026-03-17 | 2045-01-17 | 0 | 31 |
| 12576106 | Compositions of nitrates and methods of use thereof | 🖼🧊📄§ | 2026-03-17 | 2044-05-09 | 0 | 31 |
| 12576069 | Compositions and methods for treating slow-flow vascular malformations | 🖼🧊📄§ | 2026-03-17 | 2040-09-10 | 0 | 31 |
| 12576081 | Methods and compositions for improving exercise performance, single ventricular performance, cardiac output and myocardial performance index (MPI) in single ventricular heart disease, using udenafil compositions | 🖼🧊📄§ | 2026-03-17 | 2040-07-24 | 0 | 31 |
| 12577272 | CD73 inhibitors | 🖼🧊📄§ | 2026-03-17 | 2040-10-29 | 0 | 31 |
| 12577298 | Anti-IL-5 antibodies | 🖼🧊📄§ | 2026-03-17 | 2041-07-26 | 0 | 31 |
| 12576073 | Antiarrhythmic formulation | 🖼🧊📄§ | 2026-03-17 | 2042-01-13 | 0 | 31 |
| 12577320 | Anti-Claudin 18.2 antibody and antibody-drug conjugate thereof | 🖼🧊📄§ | 2026-03-17 | 2042-05-07 | 0 | 31 |
| 12577313 | Anti-claudin 18.2 and anti-4-1BB bispecific antibodies and uses thereof | 🖼🧊📄§ | 2026-03-17 | 2042-03-01 | 0 | 31 |
| 12576037 | Polymer-encapsulated drug particles | 🖼🧊📄§ | 2026-03-17 | 2041-02-19 | 0 | 31 |